← Leaderboards
Stephen Y Lai
University Of Pittsburgh At Pittsburgh
$10,561,066
Attributed
$15,701,020
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.6M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,947,437 · 16
By mechanism
P01$8,614,286 · 4
R01$8,065,926 · 3
U01$2,109,951 · 1
U54$1,118,668 · 2
T32$1,095,142 · 1
R21$794,799 · 2
Top collaborators
- Clifton David Fuller11 shared
- Kristy Brock6 shared
- James A Bankson4 shared
- Katherine Arnold Hutcheson4 shared
- Vlad C Sandulache4 shared
- Flordeliza S Villanueva3 shared
- Konstantin V Sokolov2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Matthew Louis Hedberg$134,632
- Flordeliza S Villanueva$15,503,746
- Grace Conway$212,978
- Adam Forrest$49,538
Others in their field
Top investigators on “Radiation Therapy”
- Philip J Disaia · University Of California Irvine$132,438,187
- Walter John Curran · Thomas Jefferson University$132,004,598
- Richard L Schilsky · University Of Chicago$123,524,424
- Norman Wolmark · Nsabp Foundation, Inc.$104,937,424
- Monica M Bertagnolli · Strang Cancer Prevention Center$66,963,796
- Charles A Coltman · Southwest Oncology Group$64,545,998
Research focus
Radiation TherapyImageToxic EffectMagnetic Resonance ImagingHead And Neck CancerTumorDoseMonitorHead And Neck StructureMalignant NeoplasmsTumor GrowthIn VivoDiagnosisProspectiveMissionResponsePublic HealthInnovationMortalitySolid NeoplasmTreatment ResponseNeoplastic CellIn VitroCancer Therapy
Grant awards (44)
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery$2,392,505
P01 · FY2025 · CA
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship$2,341,478
P01 · FY2025 · CA
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer$1,945,952
R01 · FY2025 · CA · contact PI
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)$704,812
U01 · FY2025 · DE · contact PI
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma$643,088
R01 · FY2025 · DE · contact PI
Project 1: InHANCE: Novel Biomedical Imaging Approaches to Address Radiation-Induced Toxicity for Head and Neck Cancer Patients$594,305
P01 · FY2025 · CA · contact PI
Project 1: OPC-ORN$381,354
P01 · FY2025 · CA · contact PI
Image Guided Cancer Therapy Training Program$341,513
T32 · FY2025 · CA
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers$195,368
U54 · FY2025 · CA · contact PI
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery$64,622
P01 · FY2025 · CA
09 Head and Neck Cancer$24,691
P30 · FY2025 · CA · contact PI
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship$2,447,812
P01 · FY2024 · CA
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)$687,801
U01 · FY2024 · DE · contact PI
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma$628,900
R01 · FY2024 · DE · contact PI
Project 1: OPC-ORN$392,210
P01 · FY2024 · CA · contact PI
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers$262,242
U54 · FY2024 · CA · contact PI
Image Guided Cancer Therapy Training Program$136,294
T32 · FY2024 · CA
09 Head and Neck Cancer$23,220
P30 · FY2024 · CA · contact PI
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer$1
R01 · FY2024 · CA · contact PI
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)$717,338
U01 · FY2023 · DE · contact PI
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer$657,066
R01 · FY2023 · CA · contact PI
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma$654,911
R01 · FY2023 · DE · contact PI
Image Guided Cancer Therapy Training Program$313,653
T32 · FY2023 · CA
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers$269,807
U54 · FY2023 · CA · contact PI
Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions$222,661
R21 · FY2023 · CA
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer$675,133
R01 · FY2022 · CA · contact PI
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers$391,251
U54 · FY2022 · CA · contact PI
Image Guided Cancer Therapy Training Program$303,682
T32 · FY2022 · CA
Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions$189,338
R21 · FY2022 · CA
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$657,315
R01 · FY2020 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$33,177
R01 · FY2020 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$657,315
R01 · FY2019 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$10,752
R01 · FY2019 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$657,315
R01 · FY2018 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$657,315
R01 · FY2017 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$187,686
R01 · FY2016 · DE · contact PI
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis$469,629
R56 · FY2015 · DE · contact PI
Optimizing Radiosensitization in Anaplastic Thyroid Cancer with Metabolic Imaging$208,800
R21 · FY2015 · CA · contact PI
Optimizing Radiosensitization in Anaplastic Thyroid Cancer with Metabolic Imaging$174,000
R21 · FY2014 · CA · contact PI
Regulation of Invasion and Metastasis by HIF-1 Oral Squamous Cell Carcinoma$126,225
K08 · FY2010 · DE · contact PI
Regulation of Invasion and Metastasis by HIF-1 Oral Squamous Cell Carcinoma$126,225
K08 · FY2009 · DE · contact PI
Regulation of Invasion and Metastasis by HIF-1 Oral Squamous Cell Carcinoma$126,225
K08 · FY2008 · DE · contact PI
Regulation of Invasion and Metastasis by HIF-1 Oral Squamous Cell Carcinoma$126,225
K08 · FY2007 · DE · contact PI
Regulation of Invasion and Metastasis by HIF-1 Oral Squamous Cell Carcinoma$126,225
K08 · FY2006 · DE · contact PI